IP Library Granted Patent US 12,194,239
Granted Patent B2
US 12,194,239 · App. 18/586,694 · Granted Jan 14, 2025

Respiratory mask

Inventors: Lee James Veliss (Rotterdam, NL); Carmel Therese Harrington (Sydney, AU); Philip Rodney Kwok (Sydney, AU); Philip John Gunning (Sydney, AU); Joshua Adam Gudiksen (Sydney, AU); Bart Jeremy Caffin (Sydney, AU); Richard Sokolov (Sydney, AU); Ian Frederick Johnson (Sydney, AU); Eric Siu (Sydney, AU)
Assignee: ResMed Pty Ltd
A61M16/06A61M16/0616A61M16/0622A61M16/0683A61M16/0825A61M16/0816A61M2210/0618
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,194,239
App. No.
18/586,694
Granted
Jan 14, 2025
Kind
B2
Abstract

A flexible patient interface structure includes a posterior portion with at least one thin flexible membrane configured to form a seal with the patient's face in use. A wall thickness of the posterior portion is varied. An anterior portion of the flexible patient interface forms a chamber with the posterior portion and has a central gas washout vent region. A wall thickness of the anterior portion is thicker at the central gas washout vent region than at other adjacent regions. First and second laterally extending protrusions are configured to receive the breathable gas from an air delivery tube or air delivery tube connector. The central gas washout vent region is located between the first and second laterally extending protrusions and comprises an array of vent openings. Each of the first and second laterally extending protrusions terminates at a distal end that is furthest from the other laterally extending protrusion.

Claims (59)

1. A flexible patient interface structure arranged to sealingly interface with and deliver breathable gas to a nose of a patient in use, the flexible patient interface structure comprising:

a posterior portion comprising at least one thin flexible membrane configured to form a seal with the patient's face in use, a wall thickness of the posterior portion being varied;

an anterior portion, at least part of the anterior portion being formed from an elastomeric material with a varied wall thickness;

a first laterally extending protrusion configured to receive the breathable gas from an air delivery tube or air delivery tube connector;

a second laterally extending protrusion configured to receive the breathable gas from the air delivery tube or the air delivery tube connector; and

a gas washout vent region located between the first and second laterally extending protrusions and comprising an array of vent openings,

wherein the part of the anterior portion formed from the elastomeric material is continuous, unitarily formed, and includes at least part of the first and second laterally extending protrusions,

wherein the wall thickness of the elastomeric material is thicker in the vicinity of the gas washout vent region than toward the first and second laterally extending protrusions,

wherein the first and second laterally extending protrusions are positioned on opposite sides of a plane that bisects the patient interface structure,

wherein the thicker part of the elastomeric material intersects the plane that bisects the patient interface structure,

wherein the posterior portion and the anterior portion form a chamber,

wherein the first laterally extending protrusion terminates at a distal end that is furthest from a distal end of the second laterally extending protrusion.

2. The flexible patient interface structure of claim 1 , wherein each of the first and second laterally extending protrusions comprises a first sub portion and a second sub portion connected to the first sub portion by a flange, a cross-section of the first sub portion being smaller than a cross-section of the second sub portion.

3. The flexible patient interface structure of claim 1 , wherein the anterior and posterior portions are formed of elastomeric material.

4. The flexible patient interface structure of claim 3 , wherein the elastomeric material comprises silicone or foam.

5. The flexible patient interface structure of claim 1 , wherein the anterior and posterior portions are translucent, transparent, or water clear.

6. The flexible patient interface structure of claim 1 , wherein an aperture is formed in the at least one thin flexible membrane, the aperture being positioned to discharge the breathable gas to the patient's airways, in use.

7. The flexible patient interface structure of claim 1 , wherein the at least one thin flexible membrane is configured to sealingly engage the patient's face at a location between the patient's mouth and the patient's nose.

8. The flexible patient interface structure of claim 1 , wherein the anterior and posterior portions are formed from a common elastomeric body, and at least part of each of the first and second laterally extending protrusions is an extension of the elastomeric body.

9. The flexible patient interface structure of claim 1 , wherein the first and second laterally extending protrusions extend in substantially opposite directions away from the gas washout vent region.

10. The flexible patient interface structure of claim 1 , wherein each of the first and second laterally extending protrusions comprises a first sub portion and a second sub portion connected to the first sub portion by a flange, a cross-section of the first sub portion being smaller than a cross-section of the second sub portion,

wherein the anterior and posterior portions are formed of elastomeric material,

wherein the elastomeric material comprises silicone or foam,

wherein the anterior and posterior portions are translucent, transparent, or water clear,

wherein an aperture is formed in the at least one thin flexible membrane, the aperture being positioned to discharge the breathable gas to the patient's airways, in use,

wherein the at least one thin flexible membrane is configured to sealingly engage the patient's face at a location between the patient's mouth and the patient's nose, and

wherein the first and second laterally extending protrusions extend in substantially opposite directions away from the gas washout vent region.

11. A patient interface system configured to deliver breathable gas to a patient, the patient interface system comprising:

the flexible patient interface structure of claim 1 ;

headgear configured to support the flexible patient interface on the patient's head; and

an air delivery tube connected to either one of the first and second laterally extending protrusions.

12. The flexible patient interface structure of claim 1 , wherein at least one thin flexible membrane is configured to remain outside of the patient's nasal passage when the flexible patient interface structure is mounted to the patient's face.

13. The flexible patient interface structure of claim 1 , wherein the first and second laterally extending protrusions lack an outwardly extending circumferential flange at their terminal ends.

14. A flexible patient interface structure arranged to sealingly interface with and deliver breathable gas to a nose of a patient in use, the flexible patient interface structure comprising:

an elastomeric main body that forms a plenum chamber and has an anterior surface and a posterior surface, the posterior surface being configured to sealingly engage the patient's face and wall thickness of the posterior surface being varied;

a first protrusion extending laterally from the elastomeric main body and configured to receive the breathable gas from an air delivery tube or air delivery tube connector;

a second protrusion extending laterally from the elastomeric main body and configured to receive the breathable gas from an air delivery tube or air delivery tube connector; and

a central gas washout vent region located between the first and second protrusions and comprising an array of vent openings,

wherein the anterior surface of the elastomeric main body is a continuous, integrally formed surface, includes at least part of the first protrusion and the second protrusion and has a varied wall thickness so that the wall thickness of the anterior surface is greater in the vicinity of the central gas washout vent region than at other adjacent regions of the of the anterior surface of the elastomeric main body,

wherein the first and second protrusions are positioned on opposite sides of a plane that bisects the patient interface structure, and

wherein the portion of the anterior surface with the greater wall thickness intersects the plane that bisects the patient interface structure.

15. The flexible patient interface structure of claim 14 , wherein each of the first and second protrusions comprises a first sub portion and a second sub portion connected to the first sub portion by a flange, a cross-section of the first sub portion being smaller than a cross-section of the second sub portion.

16. The flexible patient interface structure of claim 14 , wherein the posterior surface of the plenum chamber is configured to sealingly engage the patient's face at a location between the patient's mouth and the patient's nose.

17. The flexible patient interface structure of claim 14 , wherein the plenum chamber and the first and second protrusions are translucent, transparent, or water clear.

18. The flexible patient interface structure of claim 14 , wherein the posterior surface of the plenum chamber forms an aperture configured to discharge the breathable gas to the patient's airways.

19. The flexible patient interface structure of claim 14 , wherein a portion of the elastomeric main body is superior to the first and second protrusions.

20. The flexible patient interface structure of claim 14 , wherein at least part of each of the first and second protrusions is an extension of the elastomeric main body.

21. The flexible patient interface structure of claim 14 , wherein each of the first and second protrusions comprises a first sub portion and a second sub portion connected to the first sub portion by a flange, a cross-section of the first sub portion being smaller than a cross-section of the second sub portion,

wherein the posterior surface of the plenum chamber is configured to sealingly engage the patient's face at a location between the patient's mouth and the patient's nose,

wherein the plenum chamber and the first and second protrusions are translucent, transparent, or water clear,

wherein the posterior surface of the plenum chamber forms an aperture configured to discharge the breathable gas to the patient's airways,

wherein a portion of the elastomeric main body is superior to the first and second protrusions, and

wherein the at least part of each of the first and second protrusions is an extension of the elastomeric main body.

22. A patient interface system configured to deliver breathable gas to a patient, the patient interface system comprising:

the flexible patient interface structure of claim 14 ;

headgear configured to support the flexible patient interface on the patient's head; and

an air delivery tube connected to either one of the first and second protrusions.

23. The flexible patient interface structure of claim 14 , wherein the posterior surface is configured to sealingly engage the patient's face without being received within the patient's nasal passages.

24. The flexible patient interface structure of claim 14 , wherein the first and second protrusions lack an outwardly extending circumferential flange at their terminal ends.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 26, 2024
From: VELISS, LEE JAMES; HARRINGTON, CARMEL THERESE; KWOK, PHILIP RODNEY; GUNNING, PHILIP JOHN; GUDISKEN, JOSHUA ADAM; CAFFIN, BART JEREMY; SOKOLOV, RICHARD; JOHNSON, IAN FREDERICK; SIU, ERIC
To: RESMED LIMITED
Reel/Frame 066556/0144 →
CHANGE OF NAME AND CHANGE OF ADDRESS Recorded Feb 26, 2024
From: RESMED LIMITED
To: RESMED PTY LTD
Reel/Frame 066676/0071 →
Priority Claims (1)
AU 2007901078 · Mar 2, 2007 · national
Continuity (6)
Continuation 17362125 · Jun 29, 2021
Continuation 15961138 · Apr 24, 2018
Continuation 12377801
Provisional Application 61025427 · Feb 1, 2008
Provisional Application 60947509 · Jul 2, 2007
Related Publication 20240198027A1 · Jun 20, 2024
References Cited (100)
US 428592A · Chapman · 1890 [cited by applicant]
US 1206045A · Smith · 1916 [cited by applicant]
US 1395948A · Bernhard · 1921 [cited by applicant]
US 1632449A · McKesson · 1927 [cited by applicant]
US 2023267A · De Saint et al. · 1935 [cited by applicant]
US 2104016A · Biggs · 1938 [cited by applicant]
US 2241535A · Boothby · 1941 [cited by applicant]
US 2290885A · Lehmberg · 1942 [cited by applicant]
US 2348277A · Boothby et al. · 1944 [cited by applicant]
US 2625155A · Engelder · 1953 [cited by applicant]
US 3667475A · Venturelli et al. · 1972 [cited by applicant]
US 3828773A · Buch et al. · 1974 [cited by applicant]
US 4015598A · Brown · 1977 [cited by applicant]
US 4219020A · Czajka · 1980 [cited by applicant]
US 4265239A · Fischer, Jr. et al. · 1981 [cited by applicant]
US 4354488A · Bartos · 1982 [cited by applicant]
US 4449526A · Elam · 1984 [cited by applicant]
US 4459983A · Beyreuther et al. · 1984 [cited by applicant]
US 4590951A · O'Connor · 1986 [cited by applicant]
US 4603692A · Montesi · 1986 [cited by applicant]
US 4751924A · Hammerschmidt et al. · 1988 [cited by applicant]
US 4770169A · Schmoegner et al. · 1988 [cited by applicant]
US 4782832A · Trimble et al. · 1988 [cited by applicant]
US 4803981A · Vickery · 1989 [cited by applicant]
US 5018519A · Brown · 1991 [cited by applicant]
US 5086769A · Niemeyer · 1992 [cited by applicant]
US 5109839A · Blasdell et al. · 1992 [cited by applicant]
US 5269296A · Landis · 1993 [cited by applicant]
US 5662101A · Ogden et al. · 1997 [cited by applicant]
US 5711296A · Kolobow · 1998 [cited by applicant]
US 5722392A · Skimming et al. · 1998 [cited by applicant]
US 6019101A · Cotner · 2000 [cited by examiner]
US 6044844A · Kwok · 2000 [cited by examiner]
US 6374826B1 · Gunaratnam et al. · 2002 [cited by applicant]
US 6418928B1 · Bordewick et al. · 2002 [cited by applicant]
US 6457472B1 · Schwartz · 2002 [cited by applicant]
US 6561190B1 · Kwok · 2003 [cited by examiner]
US 6595215B2 · Wood · 2003 [cited by applicant]
US 6631718B1 · Lovell · 2003 [cited by applicant]
US 6851428B2 · Dennis · 2005 [cited by applicant]
US 6996857B2 · Fukasawa · 2006 [cited by applicant]
US 7827990B1 · Melidis et al. · 2010 [cited by applicant]
US 9981102B2 · Veliss et al. · 2018 [cited by applicant]
US 11077272B2 · Veliss et al. · 2021 [cited by applicant]
US 20020059935A1 · Wood · 2002 [cited by applicant]
US 20030079749A1 · Strickland · 2003 [cited by examiner]
US 20030116160A1 · Kwok · 2003 [cited by applicant]
US 20030154978A1 · Gradon et al. · 2003 [cited by applicant]
US 20030154980A1 · Berthon-Jones et al. · 2003 [cited by applicant]
US 20030183227A1 · Klemperer · 2003 [cited by applicant]
US 20030196656A1 · Moore et al. · 2003 [cited by applicant]
US 20030221691A1 · Biener et al. · 2003 [cited by applicant]
US 20040045550A1 · Lang · 2004 [cited by applicant]
US 20040226566A1 · Gunaratnam · 2004 [cited by examiner]
US 20050033247A1 · Thompson · 2005 [cited by examiner]
US 20050066976A1 · Wondka · 2005 [cited by applicant]
US 20050199242A1 · Matula · 2005 [cited by examiner]
US 20050205096A1 · Matula · 2005 [cited by examiner]
US 20050241644A1 · Gunaratnam et al. · 2005 [cited by applicant]
US 20060005840A1 · Cannon · 2006 [cited by applicant]
US 20060180149A1 · Matarasso · 2006 [cited by applicant]
US 20060243279A1 · Hinkle · 2006 [cited by applicant]
US 20070044804A1 · Matula et al. · 2007 [cited by applicant]
US 20100313891A1 · Veliss et al. · 2010 [cited by applicant]
US 20180236198A1 · Veliss et al. · 2018 [cited by applicant]
US 20210330921A1 · Veliss et al. · 2021 [cited by applicant]
NZ 526168 · 2004 [cited by applicant]
NZ 539836 · 2007 [cited by applicant]
WO 9617643A1 · 1996 [cited by applicant]
WO 0132250A1 · 2001 [cited by applicant]
WO 0162326 · 2001 [cited by applicant]
WO 03090827A1 · 2003 [cited by applicant]
WO 2004032727A2 · 2004 [cited by applicant]
WO 2004073777A1 · 2004 [cited by applicant]
WO 2004073778 · 2004 [cited by applicant]
WO 2005063328 · 2005 [cited by applicant]
WO 2005097247 · 2005 [cited by applicant]
WO 2007009182 · 2007 [cited by applicant]
WO 2007009782A1 · 2007 [cited by applicant]
WO 2007022562 · 2007 [cited by applicant]
WO 2007041786A1 · 2007 [cited by applicant]
WO 2007045023A1 · 2007 [cited by applicant]
Communication dated Sep. 28, 2021 issued in European Application No. 19179877.6 (4 pages). [cited by applicant]
Extended European Search Report dated Jan. 13, 2020 issued in European Application No. 19179877.6 (14 pages). [cited by applicant]
Partial European Search Report dated Sep. 6, 2019 issued in European Application No. 19179877.6 (15 pages). [cited by applicant]
First Amended Counterstatement dated Feb. 20, 2017 filed in New Zealand Application No. 615209 (32 pages). [cited by applicant]
Communication dated Nov. 16, 2016 issued in European Application No. 08706150.3 (8 pages). [cited by applicant]
Further Examination Report dated Dec. 1, 2014 issued in New Zealand Application No. 615209 (2 pages). [cited by applicant]
Further Examination Report dated May 4, 2015 issued in New Zealand Application No. 615209 (2 pages). [cited by applicant]
Further Examination Report dated Jun. 24, 2015 issued in New Zealand Application No. 615209 (2 pages). [cited by applicant]
Patent Examination Report No. 1 mailed Aug. 14, 2014 in Australian Application No. 2013219139 (3 pages). [cited by applicant]
Merriam-Webster website, dictionary entry for “structure”. Jul. 14, 2014. http://www.meriam-webster.com/dictionary/structure. [cited by applicant]
Extended European Search Report mailed Jan. 16, 2014 in European Appln. No. EP 08706150.3 (12 pages). [cited by applicant]
Further Examination Report mailed Oct. 2, 2013 in New Zealand Application No. 600517 (2 pages). [cited by applicant]
First Examination Report mailed Sep. 13, 2013 in New Zealand Application No. 615209 (2 pages). [cited by applicant]
Examination Report mailed Jun. 14, 2012 in New Zealand Application No. 600517 (2 pages). [cited by applicant]
Examiner's First Report mailed Jun. 6, 2012 in Australian Appln. No. 2008222587 (3 pages). [cited by applicant]
International Preliminary Report on Patentability mailed Sep. 8, 2009 in PCT/AU2008/000270. [cited by applicant]
International Search Report mailed Jul. 30, 2008 in PCT/AU2008/000270. [cited by applicant]
Examination Report mailed Feb. 16, 2011 in New Zealand Application No. 580173 (2 pages). [cited by applicant]